Exergaming Intervention in ALL Patients
Completed · Not applicable
Conditions studied: Acute Lymphoblastic Leukemia
In brief
This is a pilot feasibility study to collect preliminary data for a large-scale exergaming intervention in children undergoing maintenance therapy for Acute Lymphoblastic Leukemia (ALL). Patients, ages 5-17 years will be randomized to the intervention or non-intervention control group. The intervention will consist of 30 minute sessions of exergaming 3-5 times a week for 6 months, with weekly assessment of exercise level and phone calls by kinesiology graduate students for safety and compliance. Physical activity at baseline and at the end of study will be assessed using accelerometers. Outcome measures will include: anthropometrics, blood pressure, body composition, visceral fat, vascular function, fasting insulin, fasting glucose, LDL-cholesterol, HDL- cholesterol, triglycerides, functional mobility and endurance, and strength.
Key facts
- Study ID
- NCT02118324
- Run by
- University of Minnesota
- People needed
- 35
- Starts
- 2014-03-01
- Expected to finish
- 2016-01-01
- Last updated by the study team
- 2017-03-14
Who can join
Age: 5 and older, up to 17. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Eligibility will not be restricted by race or sex
- Pediatric patients with ALL diagnosis, treated at the University of Minnesota Amplatz Children's Hospital or Children's Hospitals and Clinics of Minnesota
- At least 3 months into the maintenance phase, with at least 6 months left of maintenance therapy
- Age 5-17 years at time of study enrollment
- Not smoking
- Currently not involved in a regular (3 times per week) exercise program
You may not qualify if…
- Individuals with a physical or mental impairment which would preclude their ability to perform the intervention.
- Bone marrow transplant recipients.
- Any woman currently pregnant will not be eligible, but may participate 3 or more months after the end of her pregnancy if the study is still ongoing
- Due to the intervention being in English, non-English speakers will be excluded
Where it is running
- University of Minnesota Amplatz Children's Hospital — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.